Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein.
about
Epidemiology and differential diagnosis of nasal polypsWill chronic e-cigarette use cause lung disease?Resveratrol enhances airway surface liquid depth in sinonasal epithelium by increasing cystic fibrosis transmembrane conductance regulator open probabilityPulmonary emphysema in cystic fibrosis detected by densitometry on chest multidetector computed tomographyVocal fold ion transport and mucin expression following acrolein exposure.Sinupret activates CFTR and TMEM16A-dependent transepithelial chloride transport and improves indicators of mucociliary clearance.Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiencyCigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.Comparison of cystic fibrosis transmembrane conductance regulator (CFTR) and ciliary beat frequency activation by the CFTR Modulators Genistein, VRT-532, and UCCF-152 in primary sinonasal epithelial cultures.Correlation of T2R38 taste phenotype and in vitro biofilm formation from nonpolypoid chronic rhinosinusitis patients.Chlorogenic Acid Activates CFTR-Mediated Cl- Secretion in Mice and Humans: Therapeutic Implications for Chronic Rhinosinusitis.Cystic fibrosis transmembrane conductance regulator activation by the solvent ethanol: implications for topical drug delivery.Assessment of acquired mucociliary clearance defects using micro-optical coherence tomography.Submucosal gland mucus strand velocity is decreased in chronic rhinosinusitis.Medical and Surgical Advancements in the Management of Cystic Fibrosis Chronic Rhinosinusitis.
P2860
Q24614953-D792187E-4270-4BA8-9B4E-3F839AB8631FQ28267832-CCE14B8F-7937-4BB8-9710-19FBEBD08625Q28535395-C0AAF95A-7385-4CFB-80A7-5EEA70D416DEQ31133549-92611895-BCE2-4D08-B2C2-94A6FD358BD8Q35013839-F2E4ED2D-F620-4FE4-A888-A82B80DA2137Q35223720-03416B19-54C6-4583-AEE5-24062DF0040EQ35623246-B85D64D7-B70B-4F46-A45F-F6E3044056DAQ37572359-5A38F4E6-DC2F-45FE-9768-8A8E7D729CEDQ37601753-9B237323-1A66-443F-8C39-EDA618274200Q40953303-C230A552-6987-4C7B-A5B5-B9ACDC2E7496Q42117646-E36EA7E0-B85D-4C6C-A3A0-BBF3CD14C6A5Q42779958-EB05F947-3ABF-4EE0-B631-F92A4D151A81Q46804240-62243857-77DC-49B8-89F5-D120A5F9C992Q47740722-B174BD22-DC66-4298-81E6-83FC360E5734Q49490627-8FCBC762-A38F-4416-B774-B47546E2B134
P2860
Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cystic fibrosis transmembrane ...... tobacco smoke toxin acrolein.
@ast
Cystic fibrosis transmembrane ...... tobacco smoke toxin acrolein.
@en
type
label
Cystic fibrosis transmembrane ...... tobacco smoke toxin acrolein.
@ast
Cystic fibrosis transmembrane ...... tobacco smoke toxin acrolein.
@en
prefLabel
Cystic fibrosis transmembrane ...... tobacco smoke toxin acrolein.
@ast
Cystic fibrosis transmembrane ...... tobacco smoke toxin acrolein.
@en
P2093
P2860
P356
P1433
P1476
Cystic fibrosis transmembrane ...... tobacco smoke toxin acrolein.
@en
P2093
Angela Blount
Bradford A Woodworth
Daniel Skinner
Eric J Sorscher
Frederick A Kebbel
Michael Chestnut
Nathan S Alexander
Shaoyan Zhang
Stephen B Hicks
P2860
P304
P356
10.1002/LARY.23278
P407
P577
2012-04-20T00:00:00Z